Brisbane Broncos Limited

As of December 31, 2025, Brisbane Broncos Limited carries a market capitalization of 142.16M, placing it among publicly traded companies globally. Its enterprise value stands at 106.31M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Brisbane Broncos Limited has 98.04M shares outstanding.

As of December 31, 2025, Brisbane Broncos Limited trades at a trailing price-to-earnings ratio of 18.29. The price-to-sales ratio is 1.91, and the price-to-book ratio stands at 2.65.

These figures are as of December 31, 2025. The EV/Sales ratio of 1.43 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 106.31M versus a market cap of 142.16M, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2025, Brisbane Broncos Limited maintains a current ratio of 2.23, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended December 31, 2025, Brisbane Broncos Limited posted a return on equity (ROE) of 15.33, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) is negative at -19.12, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 11.19, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 15.32, useful for judging operating efficiency across full business cycles. Inventory turnover of 9.89 indicates how many times Brisbane Broncos Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2025, Brisbane Broncos Limited recorded 3.56M in income tax expense. That works out to an effective tax rate of 31.43, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 11.34M, leaving 7.77M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Brisbane Broncos Limited's stock has gained approximately 18.15% over the past 52 weeks. The 50-day moving average sits at 1.54, while the 200-day moving average is 1.57.

Over the twelve months ended December 31, 2025, Brisbane Broncos Limited generated 74.31M in revenue and converted that into 7.77M in net income, yielding earnings per share of 0.08. EBITDA reached -12.67M, while operating income came in at -14.15M.

As of December 31, 2025, Brisbane Broncos Limited holds 35.97M in cash and equivalents against 119,916.00 in total debt, resulting in a net debt position of -35.97M. Total book value stands at 53.60M, with working capital of 23.62M providing operational flexibility.

These figures cover the twelve months ended December 31, 2025.

Over the twelve months ended December 31, 2025, Brisbane Broncos Limited posted a gross margin of 91.60, reflecting its pricing power and cost economics. The operating margin of -19.05 and net profit margin of 10.46 provide insight into operational efficiency.

Over the twelve months ended December 31, 2025, Brisbane Broncos Limited paid dividends of 0.02 per share. The dividend payout ratio of 25.22 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 1.38, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Brisbane Broncos Limited shareholders.

Brisbane Broncos Limited's most recent stock split took place on November 1, 1993 with a 13:16 split ratio.

As of December 31, 2025, Brisbane Broncos Limited has an Altman Z-Score of 5.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.